The loss of 53BP1 in ovarian cancer cells enhances cGAS-dependent antitumor immunity by enabling excessive DNA end-resection during double-strand break repair, generating cytoplasmic DNA fragments. The gene discussed is TP53BP1; the disease is ovarian carcinoma.